Planned sale

Gilead Sciences (GILD): Officer filed to sell ~$514K

ANDREW DICKINSON, Officer at Gilead Sciences, filed to sell ~$514K of Gilead Sciences shares.

~$514K
planned to sell · 3,000 shares, around Nov 16, 2026
Planned for
Nov 16, 2026
Notice filed
Nov 16, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 1, 2026Insider · 1 personInsiders: 2 sales (~$2.2M)
  2. Oct 15, 2026Insider · 2 peopleInsiders: 2 sales (~$937K)
  3. Oct 29, 2026Company filing · Form 8-K · ResultsReported its results
  4. Oct 30, 2026InsiderCEO sold ~$2.78M of GILD shares in the open market
  5. Nov 2, 2026Insider · 1 personInsiders: 5 sales (~$2.5M)
  6. Nov 4, 2026InsiderCEO sold ~$18M of GILD shares in the open market
  7. Nov 5, 2026InsiderCEO sold ~$1.72M of GILD shares in the open market
  8. Nov 6, 2026InsiderOfficer sold ~$558K of GILD shares in the open market
  9. Nov 10, 2026Government · Federal Register noticeNotice Pursuant to the National Cooperative Research and Production Act of 1993-R Consortium, Inc.
  10. Nov 12, 2026Insider · 1 personInsiders: 4 sales (~$1.8M)
  11. Nov 16, 2026Insider · 2 peopleInsiders: 4 sales (~$5.3M)
View the official recordSEC Form 144

How to read SEC Form 144

Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.

Full guide: What is an SEC Form 144?

What else is on file for Gilead Sciences

For Gilead Sciences, OQRO holds 47 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GILD page.

How this filing works

Explore the data

Common questions

Which Gilead Sciences (GILD) insider traded, and how much?

ANDREW DICKINSON, Officer at Gilead Sciences, filed to sell ~$514K of Gilead Sciences shares. 3,000 shares, Form 144 notice of a planned sale.

When did it happen, and when was it made public?

Planned for: Nov 16, 2026. Notice filed: Nov 16, 2026.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 144, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Gilead Sciences recently?

For Gilead Sciences, OQRO holds 47 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the GILD page.

Does this mean GILD stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Gilead Sciences

Everything OQRO holds on this company is on its GILD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data